These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37753040)

  • 1. Transfusion-Associated Graft-Versus-Host Disease in Adults.
    Elmakki EE; Madkhali MA; Oraibi O; Alqassimi S; Saleh E
    Cureus; 2023 Aug; 15(8):e44148. PubMed ID: 37753040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
    Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
    Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
    O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T
    Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis and Prevention of Transfusion-Associated Graft-versus-Host Disease].
    Feng FE; Wang QM; Zhu XL; Wang CC; Zhang XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1774-9. PubMed ID: 26708909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?
    Sato N; Marubashi S
    Transfus Apher Sci; 2022 Apr; 61(2):103406. PubMed ID: 35283033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated graft versus host disease.
    Parshuram C; Doyle J; Lau W; Shemie SD
    Pediatr Crit Care Med; 2002 Jan; 3(1):57-62. PubMed ID: 12793924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
    Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
    Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient.
    Patel KK; Patel AK; Ranjan RR; Shah AP
    Indian J Hematol Blood Transfus; 2010 Sep; 26(3):92-5. PubMed ID: 21886390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
    Aizawa K; Peltier D; Matsuki E; Toubai T
    Transfus Apher Sci; 2022 Apr; 61(2):103405. PubMed ID: 35210194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?
    Li M; Irsch J; Corash L; Benjamin RJ
    Transfus Apher Sci; 2022 Apr; 61(2):103404. PubMed ID: 35288055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of transfusion-associated graft-vs-host disease after open heart surgery.
    Tanaka K; Aki T; Shulman HM; Sullivan KM; Tanaka A; Nagasako R
    Arch Dermatol; 1992 Nov; 128(11):1503-6. PubMed ID: 1444505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Nagendra GT; M N R; Hegde DP; Damodar S; Gupta R
    Indian J Crit Care Med; 2008 Jul; 12(3):124-7. PubMed ID: 19742259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.